Navigation Links
Prion disease treatable if caught early

Studies in mice have indicated that the effects of prion disease could be reversed if caught early enough. The researchers said that their findings support developing early treatments that aim to reduce levels of prion protein in the brains of people with prion disease. Also, they said that their findings suggest testing the efficacy of treatments in a new way: by analyzing their cognitive effects in prion-infected mice.

The researchers, Giovanna Mallucci and colleagues, reported their findings in the February 1, 2007 issue of the journal Neuron, published by Cell Press.

Prion disease—such as the version of Creutzfeldt-Jakob disease believed to be contracted from cattle with "mad cow disease"—is caused by aberrant, infective proteins. It has been thought that the disease is untreatable.

However, in previous studies with prion-infected mice, Mallucci and colleagues found that early brain degeneration can be reversed if prions are depleted in neurons.

In the new studies published in Neuron, they established that cognitive and behavioral impairments—which appear early in humans with prion disease—can be reversed if prion depletion is done early. What’s more, they found that the neurological pathology of the disease is reversed along with the cognitive and behavioral deficits.

In their studies, the researchers measured the effects of prion disease on the animals?ability to discriminate novel objects in their cage and on normal burrowing behavior. In both cases, deficits in those abilities appeared early in the disease. Also, studies of the animals?brain tissue revealed a parallel impairment of signaling among brain cells.

However, when the researchers manipulated the animals to deplete their brains of the prion protein, their memory ability and burrowing behavior recovered. Importantly, found the researchers, the signaling among brain cells also recovered.

"Overall, we conclude that the dramatic benefits
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection
2. Active Vaccine Prevents Mice From Developing Prion Disease
3. Prions rapidly remodel good protein into bad, Brown study shows
4. Prion find points way to test for human mad cow disease
5. Neuronal traffic jam marks early Alzheimers disease
6. Scientists detect probable genetic cause of some Parkinsons disease cases
7. Ecological destruction fuels emerging diseases
8. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
9. U of M researcher examines newly emerging deadly disease
10. Marburg virus disease in Angola - update
11. Molecular machine may lead to new drugs to combat human diseases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prion disease treatable caught early

(Date:11/4/2009)...ver, BC - Lowly bacteria, it turns out, hold the p...g plants around the world clean up toxic waste on ...cifically RDX, were invented back in World War II ...es. These high-energy compounds are often used to...ersion of TNT. , But with increased knowledge ...
(Date:11/4/2009)...iversity of Oklahoma at Norman has received more t...ng agencies as part of the federal stimulus progra...ceived by OU researchers to $23 million. Thirty-t...h ranging from archaeology to weather. , "The un...approach to matching areasof scholarly excellence ...
(Date:11/4/2009)...DISON, N.J., Oct. 20 Que...ld,s leading provider of diagnostic testing, infor...quarter ended September 30, 2009, income from cont...er diluted share, from $160 million, or $0.81 per ...008, third quarter results were reduced by a $0.03...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 1Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 2Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 1Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 2
... of an academic medical centers success in fosteri...07 was a banner year for Oregon Health & Science U...tions, more than in any previous year in the unive..., Five new startup companies based on OHSU disco... the total to 33 since 2000 and 64 since the early...
...07 Just in time for Halloween, researchers are re...impact of social stress, in an article scheduled f...gical Psychiatry. As children and adults alike ge...spooky holiday, this study lends a further underst...lon and colleagues at the National Institute of Me...
...bal Solutions, LLC,( http://www.mosaicgs.com ), a ...s and solutions, has just released the Mosaic Inte... ordinary enterprise-class network,video recording...make the,job of video-oriented surveillance dramat...tform takes advantage of IP/Network video surveill...
Other Biology News:OHSU turns innovations into commercial opportunities at record pace 2OHSU turns innovations into commercial opportunities at record pace 3OHSU turns innovations into commercial opportunities at record pace 4OHSU turns innovations into commercial opportunities at record pace 5Social stress + darkness = increased anxiety 2Mosaic Intelligent Video Management System: Video Surveillance Just Got Smarter 2
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/5/2009).... 5 GenVec, Inc. (Nasdaq...r the third quarter ended September 30, 2009. GenV...share) for the three months ended September 30, 20...er share) in the comparable quarter of 2008. For t...net loss was $14.1 million ($0.15 per share), comp...
(Date:11/5/2009)..., Nov. 5 ThermoGenesis C...ative products for processing and storing adult st...rter of fiscal 2010. ,, For the quarter ended S...f $5.2 million, a 15 percent increase over revenue... The Company said the key contributors to the grow...
(Date:11/5/2009).... 5 Cepheid (Nasdaq: CP...peaking at the following investor conferences, and... Credit Suisse Healthcare Conferen...mber, 2009 at 10 a.m. Mountain Time, ...and, Tuesday, 1 December, 2009 at ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2
...t to Follow, ROCKVILLE, Md., July 31 Vanda Pharm...cal company focused on the development,and commerc...r central,nervous system disorders, today announce...nded June 30, 2008, on Tuesday, August 5, 2008, be...ease will be disseminated at that,time., Mihael H...
... BioCryst,Pharmaceuticals (Nasdaq: BCRX ) today a...sults will be released on Thursday, August 7, 2008...erence call and Webcast at 8:30 a.m.,Eastern Time ...date on the,Company,s programs. The call will be l...e Officer, and Stuart Grant, BioCryst,s Chief Fina...
...erly revenues of $27.2 million, ATLANTA, July 31 ...cal device and tissue processing company, announce...08 increased 18 percent to,$27.2 million compared ...cluding orthopaedic tissue processing revenues of ...f 2008 and 2007, respectively, total,revenues incr...
Other Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 2BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008 3CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 2CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 3CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 4CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 5CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 6CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 7CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 8CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 9CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 10CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007 11
...as an internal standard for the quantification of ...try. 5-OxoETE is a polyunsaturated keto acid forme... It stimulates cytosolic calcium levels in neutrop...imulates the migration and degranulation of eosino...
...sists of ten double-stranded RNAs, 10, 20, 30, 50,... dsRNA Marker is an ideal size marker for determin...NA band including in the dsRNA Marker is adjusted ...The dsRNA Marker is manufactured for non-denaturin...
...solid. A nucleoside antibiotic that inhibits N-lin...ycosidic protein-carbohydrate linkages. Active in...ngi, and viruses. Inhibits the expression of funct... cells. Also inhibits thrombin-induced Ca 2+ mobi...
...enzymes involved in matrix degradation. Of the six...n exist in soluble form whereas MT-MMPs exist as i...MP also known as MMP14, MMP15, MMP16 respectively ...g them to the cell surface. They have an 8 amino a...
Biology Products: